By Karen Roman Shake Shack Inc. (NYSE: SHAK) shares rose 7.79% at the closing after the company declared revenue grew 14.7% for the third quarter and same-store sales increased 4.4%, beating analysts’ expectations. This is the 15th consecutive quarter of...

By Exec Edge Editorial Staff Assailants on a motorcycle fired five shots into the car carrying Uzbekistan’s former press secretary Komil Allamjonov early Saturday morning near his home outside of the country’s capital of Tashkent. Both Allamjonov and his driver were...

By Karen Roman DecisionRx said it appointed Michael Tilton as Chief Growth Officer to lead the expansion of the company’s Medication Therapy Optimization platform. Tilton’s previous roles include senior vice president at Humana, as well as other senior leadership positions...

Tech Edge hosted a fireside chat on Oct. 23 at Nasdaq MarketSite with Kevin Lynch, Chief Executive Officer at Optiv. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed how AI is reshaping the landscape of election security, cyber...

By Daniella Parra Aktis Oncology said AKY-1189 is showing promise to treat cancers such as metastatic urothelial carcinoma, breast, lung, colorectal and cervical cancers. The company said data from an oral plenary and two posters highlighted significant tumor uptake and...

By Karen Roman Mobile-gaming company Aquimo Inc. promoted Shachi Singh to chief technology officer, while Andrea Bailey joined the company as chief revenue officer. Aquimo has been expanding partnerships with major league teams in the NFL, NBA and NHL, among...

By Karen Roman Biotechnology company Medera Inc. said it will start the Cohort B (high-dose) trial of SRD-002, the first-in-human cardiac gene therapy for Heart Failure with Preserved Ejection Fraction. The company finished Cohort A (low-dose) with favorable efficacy results after...

By Daniella Parra March Biosciences has closed an oversubscribed $28.4 million Series A financing, led by Mission BioCapital and 4BIO Capital to advance its innovative autologous chimeric antigen receptor T-cell (CAR-T) therapy and more, it said. The therapy is aimed...

By Karen Roman MOBILion Systems, Inc. revealed its hi-res mass spectrometry functionality with implementations for proteomics, metabolomics and lipidomics, among others. The company’s approach is up to 5-10 times faster than current systems, close to 100% ion utilization efficiency and it...

By Karen Roman Global surgical robotics company CMR Surgical said the FDA has granted marketing authorization for its Versius Surgical Robotic System in the U.S.   Versius is the world’s second most utilized surgical robotic system with over 26,000 procedures...